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ABSTRACT
A simple and rapid HPLC method was developed to evaluate and validate the assay of quercetin, kaempferol and isorhamnetin in
Ginkgo biloba extract and its products. The column used is Cosmosil 5C18-AR, and mobile phase is MeOH:0.3%H3PO4 (1:1). The correlation coefficients of linear calibration for quercetin, kaempferol and isorhamnetin are 0.9999, 0.9999, and 0.9989, respectively. The relative standard deviations of intra-day assays for quercetin, kaempferol, and isorhamnetin are 0.29%, 0.28%, and 1.90%, respectively; interday assays are 0.95%, 0.85%, and 1.67%, respectively. The recoveries of quercetin, kaempferol and, isorhamnetin are 87.4%, 94.0%, and
72.4%, respectively. The optimal condition for acid hydrolysis of flavonoid glycosides in Ginkgo biloba extract could be achieved by
refluxing with 20.0% HCl at 85˚C for 15 min or with 5.5% HCl at the same temperature for 30 min.
Key words: Ginkgo biloba extract, HPLC, quercetin, kaempferol, isorhamnetin

INTRODUCTIOM
Ginkgo Semen is the seed of Ginkgo biloba L. and classified in Ginkgoaceae. Dried Ginkgo Semen was used as a
traditional Chinese medicine with a common name “baiguo”. The components in bai-guo include proteins, lipids,
and carbohydrates. Apart from Chinese, the Westerners have
also used Ginkgo biloba leaf extract as a medicine. Flavonoid
glycosides and terpene lactones (including ginkgolides and
bilobalides) are two main groups of active components in
Ginkgo biloba leaf. Based on the literature(1-5) and the monograph reported by specialists in commission E of the Federal
Institute for Drugs and Medical Devices of Germany, the
medical functions of Ginkgo biloba include (1) improvement
of hypoxic tolerance, particularly in cerebral tissue (2) inhibition of the development of traumatically or toxically
induced cerebral edema and acceleration of its regression; (3)
inactivation of toxic oxygen radicals (flavonoids); (4) antagonism of the platelet-activating factor (PAF) by ginkgolides;
(5) protecting nerves by ginkgolides A and B and bilobalides.
Since Ginkgo biloba was proven to improve blood circulation of capillaries and cerebrum, recently it was manufactured into various products such as tablet, sugar-coated
tablet, film-coated tablet, oral solution, drop, and injection.
Therefore, the cases for registering Ginkgo biloba extract and
its derived products are increasing in Taiwan. To date,
flavonoids in these products are the only components that are
requested to assay by the manufacturers. The analysis of
flavonoids can be achieved by UV and HPLC methods.
However, due to variations in rationale and detecting compound between these two methods, the calculation and quantitation are expressed in different ways.
* Author for correspondence. Tel: 02-26531208;
Fax: 02-26531213; E-mail: kuochingwen@nlfd.gov.tw

The UV method used quercetin as the reference standard. The samples were hydrolyzed, reacted with AlCl3 to
form color, and then quantified with UV spectrophotometer.
Since the factor used to calculate the total flavonoids was not
a constant, the deviation of this method is always large. In
addition, proanthocyanidines in samples could interfere with
detection and reduce the reproducibility of the results.
Furthermore, the UV method was not specific(4) and was
gradually replaced by HPLC method. For this reason and the
suggestion of the National Laboratory of Foods and Drugs,
the Department of Health of Taiwan has stated in ordinance
1995.11.1.(7) that HPLC method is a recommended method
to examine the components in raw material of Ginkgo biloba
leaf extract and its derived products.
Using quercetin, kaempferol and isorhamnetin as the
reference standards for HPLC method, the samples were
hydrolyzed and then analyzed by HPLC. Although five kinds
of C18 columns used to analyze flavonoids have been evaluated and reported(5), this currently developed method is,
however, different from those reported and official methods
in sample pre-treatment, column and mobile phase choices,
detection wavelength, and flow rate of the mobile phase.
Thus, the objective of this research is to re-evaluate HPLC
method used to quantify quercetin, kaempferol, and isorhamnetin in Ginkgo biloba leaf extract and its derived products
and to develop an optimum separation and quantification
method. This research also studied the hydrolysis condition
of flavonoid glycosides, selection of the HPLC column and
mobile phase, repeatability of analyses, and recovery of each
standard compound. This developed method was evaluated
using commercial Ginkgo biloba products as the testing compounds in order to establish an official method to analyze
flavonoids in these products.
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MATERIALS AND METHODS

IV. Methods

I. Instruments

(I) Study of the HPLC Conditions

HITACI HPLC equipped with a L-7100 pump and a L7400 detector.

1. Selection of the Mobile Phase

II. HPLC Columns
1. Cosmosil 5C18-AR (4.6 × 150 mm, 5µm) (Waters, Milford,
MA, USA)
2. LiChrospher 100RP-18 (4.0 × 125 mm, 5 µm) (Merck,
Hohenbrunn, German)
3. µ-Bondapak C18 (3.9 × 300 mm, 10 µm) (Waters, Milford,
MA, USA)
4. Inertsil ODS-2 (4.6 × 250 mm, 5 µm) (GL Science, Kyoto,
Japan)
5. Cosmosil 5C 18 -MS (4.6 × 150 mm, 5 µ m) (Waters,
Milford, MA, USA)
6. SYMETRY (4.6 × 150 mm, 5 µm) (Waters, Milford, MA,
USA)
7. Nucleosil 5C 18 (4.6 × 150 mm, 5 µ m) (Phenomenex,
Torrance, CA, USA)
8. Hypersil 5C 18 (4.6 × 150 mm, 5 µ m) (Phenomenex,
Torrance, CA, USA)
9. PRODIGY 5 ODS-2 (4.6 × 250 mm, 5 µm) (Phenomenex,
Torrance, CA, USA)

Nine different mobile phases were evaluated to separate
quercetin, kaempferol, and isorhamnetin, and Cosmosil 5C18MS column was used as the HPLC column. The retention
time (tR), relative retention (α), and resolution (Rs) resulted
from various mobile phases were compared, and the most
appropriate mobile phase could be selected.
2. Selection of HPLC Column
Nine HPLC columns with methanol:0.3% H3PO4 (1:1)
as the mobile phase were evaluated to analyze quercetin,
kaempferol, and isorhamnetin. The retention time (tR), asymmetry of peaks (As), resolution (Rs), and plate number (N)
obtained from different columns were compared, and the best
column could be chosen.
(II) HPLC Analysis of Commercial Products
1. Preparation of the Commercial Products for HPLC
Analysis

Quercetin, kaempferol, and isorhamnetin were purchased from EXTRA SYNTHESE Co. (Genay, France).
Morin was from NACALAI Co. (Kyoto, Japan).

Four to five sample tablets (or 5.0 mL for liquid sample)
were ground and 20 mL 80% methanol solution was added to
dissolve the sample. After shaking for 30 min, the mixture
was placed aside until two phases were separated. Ten mL of
the upper layer was removed and treated with 10 mL 5.5%
HCl solution. The solution was refluxed in 85˚C water bath
for 30 min. Finally the solution was filtered and ready for
HPLC analysis.

(II) Reagents

2. HPLC Conditions

Na2HPO4•12H2O, NaH2PO4•2H2O, and KH2HPO4 were
from WAKO Co. (Osaka, Japan); sodium 1-octanesulfonate
(PICB8) was from SIGMA Co. (St. Louis, MO, USA); phosphoric acid and acetic acid were from Merck Co.
(Hohenbrunn, Germany).

Column, Cosmosil 5C18-AR (150 mm); mobile phase,
methanol:0.3% H3PO4 (1:1); flow rate, 1.0 mL/min; detection wavelength, 370 nm.

III. Standard Compounds and Reagents
(I) Standard Compounds

(III) Standard Curves of Quercetin, Kaempferol, and
Isorhamnetin

(III) Solvents
Methanol and acetonitrile were obtained from LABSCAN Co. (Dublin, Ireland); tertrahydrofuran (THF) was
from Merck Co. All solvents were HPLC grade.
(IV) Samples
Ginkgo biloba extract was purchased from Tradshine
Co. Ltd. (imported from Boral Quimica, S.A., Spain). Twelve
commercial available Ginkgo biloba products includes 8
samples of film-coated tablets and one sample of sugar-coated tablet, tablet, drop, and oral solution.

Quercetin, kaempferol, isorhamnetin, and morin (internal standard) were measured precisely and were dissolved
separately in 80% methanol solution. Quercetin solution was
further diluted to 500, 110, 53, and 26 µg/mL; kaempferol
solution to 470, 100, 50, and 25 µg/mL; isorhamnetin solution to 270, 54, 27, and 13 µg/mL. Internal standard (44
µg/mL) was spiked into each dilution, which was then analyzed by HPLC. The standard curves were obtained by plotting the peak area ratios (Y-axis) of standard compounds to
the internal standard versus the concentrations of standard
compound (X-axis). According to these standard curves, the
linear regressions (Y = mX + b) and correlation coefficients
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were computed.
(IV) Investigation of Hydrolysis Conditions
1. Concentration of HCl
Ten mL of different concentrations of methanolic HCl
solution (2.25%, 5.5%, 10%, 20%, and 25%) were added to
five tubes (10 mL each) of diluted Ginkgo biloba extract (1.5
g sample dissolved in 200 mL 80% methanol solution) separately. Each mixture was refluxed in an 85˚C water bath for
30 min, after cooling, each mixture was spiked with internal
standard. Finally, the volume was brought to 25 mL with
80% methanol solution and then was analyzed by HPLC. The
HPLC conditions were the same as described above.
2. Hydrolysis Time
Ten mL of HCl solution (20%) was added into 4 tubes of
diluted Ginkgo biloba extract (10 mL each), and each mixture was refluxed in a water bath (85˚C) for 15, 30, 60, and
120 min, respectively. After cooling, each mixture was
spiked with I.S. and brought to 25 mL with 80% methanol
solution. For another set of test, the same procedure was carried out except 20% HCl solution was replaced by 5.5% HCl.
(V) Intra-Day and Inter-Day Assays of Standard Compounds
The testing concentrations for quercetin, kaempferol,
and isorhamnetin solutions were within the concentration
ranges of their respective standard curves. Quercetin (0.11
mg/mL), kaempferol (0.10 mg/mL), and isorhamnetin (0.054
mg/mL) were analyzed by HPLC for 5 times/day and 1
time/day for 5 consecutive days. The resulting peak area
ratios were used to calculate standard deviation and relative
standard deviation.
(VI) Recovery Test
Standard solutions of quercetin (0.53, 1.06, 2.12, and
3.18 mg/mL), kaempferol (0.50, 1.0, 2.0, and 3.0 mg/mL),
and isorhamnetin (0.27, 0.54, 1.08, and 1.62 mg/mL) were
added separately into 4 tubes of diluted Ginkgo biloba extract
(3 mL each). The control tube was without addition of standard solutions. Following addition of 10 mL of 5.5% HCl,
each mixture was refluxed in an 85oC water bath for 30 min.
After cooling, each tube was spiked with I.S. and diluted to
25 mL with 80% methanol solution. After HPLC analysis,
the recovery of each standard compound could be calculated
from the resulting data.

RESULTS AND DISCUSSION
I. Study of HPLC Conditions
(I) Selection of Mobile Phase

A total of 9 mobile phases from recent registered cases
were applied to separate quercetin (Q), kaempferol (K), and
isorhamnetin (I), and tR, α, and Rs obtained from each mobile
phase was calculated. Based on the literature, the criteria for
a good separation are: α within 1.05-2.0 and Rs over 1.5. The
tR, α, and Rs of each mobile phase are listed in Table 1.
Since Q could separate well from the other two standard
compounds in all 9 mobile phases, the mobile phase, which
could best resolve K and I was chosen and used for this study.
Therefore, α and Rs of K and I obtained from these 9 mobile
phases were evaluated. As the result shown, with the exception of mobile phase M9, which could not resolve K and I, the
other 8 mobile phases were able to separate peaks Q, K, and
I, and their Rs were more than 1.5 and α between 1.05-2.0.
Of all mobile phases, M2, M3, M6, M7, and M8 resulted in a
better resolution, however, M2 containing phosphate salt
could increase the difficulties in mobile phase preparation
and HPLC column clean-up. Mobile phase M3 containing
triethylamine could emit unpleasant odor. The retention
times were too long for mobile phase M6 and M7. Therefore,
M8 (methanol:0.3%H3PO4 = 1:1) was chosen as the mobile
phase for later study. Figure 1 is the chromatogram for standard compounds using M8 as the mobile phase.
(II) Selection of HPLC Column
With M8 as the mobile phase, nine different HPLC
columns were compared to resolve quercetin (Q), kaempferol (K), and isorhamnetin (I). The tR, As, Rs, and N resulted
from different columns were listed in Table 2. Based on the
literature (5), As is the best between 1 and 1.2. Of all 9
columns, the As of column 1, 5, 6, 7, and 9 were within this
range. Among these 5 columns, column 1 (Cosmosil 5C18AR), 5 (Cosmosil 5C18-MS), and 7 (Nucleosil 5C18 100A)
were selected for better resolution (Rs > 4.5). However, column 7 was left out since its retention time was longer than
Table 1. Separation parameters with various mobile phases
Mobilea
tR(min)
phase
Q
K
I
α(K-I)
Rs(K-I)
M1
19.2
43.1
46.1
1.07
5.05
M2
11.3
21.8
24.6
1.13
5.56
M3
12.0
23.1
25.8
1.12
5.36
M4
8.0
14.6
16.8
1.15
4.44
M5
12.3
17.2
20.1
1.17
4.90
M6
21.4
47.5
52.5
1.11
6.32
M7
15.9
31.3
34.6
1.11
5.50
M8
12.1
23.3
26.0
1.11
5.22
M9
10.1
19.4
–b
–
–
a M1. Phosphate buffer (containing PICB ) : CH CN (77:23).
8
3
M2. 20 mM KH2PO4 : MeOH (51:49).
M3. Triethylamine : MeOH (53:47).
M4. 20% AcOH : MeOH (68:32).
M5. 1% AcOH : THF: MeOH (55:13:32).
M6. 0.3% H3PO4: CH3CN (77:23).
M7. MeOH : 0.3% H3PO4 : CH3CN (30:58:12).
M8. MeOH : 0.3% H3PO4 (1:1).
M9. H2O : CH3CN : Isopropanol (100:47:5) + 0.4% Citric acid.
b Isorhanetin could not be separated.
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Figure 2. Chromatogram of quercetin, kaempferol and isorhamnetin,
Column: Cosmosil 5C18-AR, Mobile phase: MeOH: 0.3%H3PO4 (1:1).

value (36556) and better antiacidity than the later. In addition, column 1 was superior in column efficiency and Rs,
therefore, it was the best choice for this study. Figure 2 is the
chromatogram for reference standards separated by column
1.
Figure 1. Chromatogram of quercetin, kaempferol and isorhamnetin,
Column: Cosmosil 5C18-MS, Mobile phase: MeOH : 0.3% H3PO4 (1:1).
Table 2. Separation and efficiency parameters with various columns
Columna
tR(min)
Q
K
I
As(K) As(I) Rs(K-I)
N
1
13.1 25.3 28.2
1.0
1.0
5.54
36556
2
7.8 14.4 16.2
1.5
1.5
3.29
18431
3
20.3 35.1 38.9
1.5
1.4
3.39
22458
4
18.4 37.5 41.1
1.3
1.3
4.29
44109
5
12.6 22.4 24.8
1.0
1.0
4.86
30830
6
10.8 19.6 21.7
1.0
1.0
4.20
24121
7
16.2 29.2 33.3
1.0
1.0
5.53
29466
8
9.8 16.9 18.9
1.5
1.1
2.83
12946
9
16.4 29.9 32.1
1.0
1.0
4.36
55033
a 1. Cosmosil 5C -AR 4.6 × 150 mm (Waters).
18
2. Lichrospher 100 RP-184.0 × 125 mm (Merck).
3. µ-Bondapak C18 3.9 × 30 mm (Waters).
4. Inertsil ODS-24.6 × 250 mm (GL Sciences Inc.).
5. Cosmosil 5C18-MS 4.6 × 150 mm (Waters).
6. SYMETRY 4.6 × 150 mm (Waters).
7. Nucleosil 5C18 100A 4.6 × 150 mm (Phenomenex).
8. HYRERSIL 5C18 4.6× 150 mm (Phenomenex).
9. PRODIGY5 ODS-2 4.6 × 250 mm (Phenomenex).

column 1 and 5, and its N value (29466) was smaller. Column
1 and 5 were similar but the former possessed a higher N

II. Standard Curves of Quercetin, Kaempferol, and
Isorhamnetin
The chromatogram of quercetin, kaempferol, and
isorhamnetin is shown in Figure 3. The linear regressions for
the standard curves of quercetin, kaempferol, and isorhamnetin were as follows:
Quercetin:
Y = 6.03X + 1.06E-03 r = 0.9999
Kaempferol:
Y = 6.09X + 2.45E-03 r = 0.9999
Isorhamnetin: Y = 1.32X + 1.44E-02 r = 0.9989
III. Investigation of Hydrolysis Conditions
All the recent registered cases for the examination of
Ginkgo biloba extract and other relevant products in Taiwan
were hydrolyzed under acid conditions. Hasler (11) and
Pietta(12) also hydrolyzed samples with HCl and under heated environments. Therefore, HCl was applied in this study
for sample hydrolysis. The testing samples were treated with
5 levels of HCl solution (2.5%, 5.5%, 10%, 20%, and 25%)
as described in Materals and Methods. The highest hydrolysis rate in these 5 treatments was assigned as 100%. As
shown in Table 3, 20% HCl solution resulted in the highest
hydrolysis rate. However, most registered cases used 5.5%
HCl solution for sample hydrolysis. For this reason, both
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5.5% and 20% were chosen to investigate the hydrolysis
time. After reflux at a water bath for 15, 30, 60, and 120 min,

the results were obtained and shown in Table 4 and Table 5.
The treatments of 20% HCl for 15 min and 5.5% HCl for 30
min achieved the similar outcome (Table 6).
IV. Precision of Analysis
Quercetin, kaempferol, and isorhamnetin were analyzed
Table 3. Relative yields of flavonoid aglycones from Ginkgo biloba
extract treated by various concentrations of hydrochloric acid (HCl)
flavonoid
Yields (%)
aglycone
2.5%
5.5%
10%
20%
25%
quercetin
62.2
84.2
91.9
100
91.9
kaempferol
58.8
78.3
90.5
100
90.0
isorhamnetin
55.8
71.4
87.1
100
92.5

Figure 3. Chromatogram of quercetin, kaempferol, isorhamnetin and
morin, Column: Cosmosil 5C 18-AR, Mobile phase : MeOH: 0.3%
H3PO4 (1:1).

Table 4. Relative yields of flavonoid aglycones from Ginkgo
extract treated with 5.5% HCl for different length of time
flavonoid
Yields (%)
aglycone
15 min
30min
1 hr
quercetin
90.1
96.3
100.0
kaempferol
91.0
100.0
100.0
isorhamnetin
94.9
100.0
89.7

biloba

Table 5. Relative yields of flavonoid aglycones from Ginkgo
extract treated with 20.0% HCl for different length of time
flavonoid
Yields (%)
aglycone
15 min
30min
1 hr
quercetin
100.0
85.5
89.2
kaempferol
100.0
86.1
86.1
isorhamnetin
100.0
86.8
71.1

biloba

2 hr
93.8
91.0
79.5

2 hr
84.3
84.7
81.6

Table 6. Comparison of flavonoid aglycone contents of a liquid product
after two different conditions of hydrolysis
Content (mg/mL)
flavonoid
5.5% HCl
20% HCl
aglycone
， 30 min
， 15 min
quercetin
0.050
0.051
kaempferol
0.038
0.041
isorhamnetin
0.036
0.036

Table 7. Inter-day and Intra-day relative standard deviation for quercetin, kaempferol and isorhamnetin
peak area of marker substance /
flavonoid
concentration
peak area of morin
mean ± S.D.a (R.S.D.%)
aglycone
(mg/mL)
inter-day
intra-day
inter-day
intra-day
1.78
1.81
1.81
1.81
1.81 ± 0.005 (0.29)
quercetin
0.11
1.78
1.82
1.80 ± 0.017 (0.95)
1.78
1.82
1.81
1.81
1.75
1.77
1.78
1.78
kaempferol
0.10
1.75
1.77
1.76 ± 0.011 (0.85)
1.78 ± 0.005 (0.28)
1.76
1.78
1.78
1.78
0.41
0.42
0.43
0.42
isorhamnetin
0.054
0.41
0.41
0.42 ± 0.007 (1.67)
0.42 ± 0.008 (1.90)
0.42
0.43
0.42
0.43
an = 5.
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Table 8. Recoveries of quercetin, kaempferol and isorhamnetin from Ginkgo biloba extrat
flavonoid aglycone
added (mg/mL)
found (mg/mL)
relative recovery (%)
0.528
0.464
87.9
quercetin
1.056
0.920
87.1
2.112
1.812
85.8
3.168
2.812
88.8

keampferol

isorhamnetin

an

0.496
0.992
1.984
2.976

0.468
0.924
1.840
2.852

94.4
93.1
92.7
95.8

0.268
0.536
1.072
1.608

0.188
0.388
0.564
0.880

70.1
72.4
72.6
74.6

mean ± S.D.a

(R.S.D.%)

87.4 ± 1.27

(1.45)

94.0 ± 1.40

(1.49)

72.4 ± 1.84

(2.54)

= 5.

respectively. These data indicated the assays were precise.
V. Recovery Test
As described above, the diluted Ginkgo biloba extract
was spiked with various concentrations of reference standards. After HPLC analysis, the recoveries of these reference
standards were calculated and listed in Table 8. The average
recoveries for quercetin, kaempferol, and isorhamnetin were
87.4%, 94.0%, and 72.4%, respectively. The lower recovery
of isorhamnetin is probably due to the minor content of this
compound in Ginkgo biloba.
VI. HPLC Analysis of the Commercial Products
The commercial Ginkgo biloba products include filmcoated tablet, sugar-coated tablet, tablet, oral solution, drop,
and injection, among them, film-coated tablet is the most
popular product. Twelve commercial products were purchased from local stores and analyzed using the currently
developed HPLC method. For different products, their excipients are also dissimilar and may interfere with HPLC analysis. However, this method was able to separate quercetin,
kaempferol, and isorhamnetin well and without any interference. The chromatogram of film-coated tablet was shown in
Figure 4.

CONCLUSIONS

Figure 4. Chromatogram of a Ginkgo product.

5 times/day and 1 time/day for 5 consecutive days. The relative standard deviations of intra-day and inter-day were listed
in Table 7. As the result shown, the relative standard deviations for the intra-day analyses for quercetin, kaempferol,
and isorhamnetin were 0.29%, 0.28%, and 1.90%, respectively; inter-day analyses were 0.95%, 0.85%, and 1.67%,

I. Based on the comparisons of retention time (tR), relative
retention time (α), asymmetry of peaks (As), resolution (Rs),
and plate number (N), application of Cosmosil 5C18-AR column and methanol:0.3% H3PO4 (1:1) as the mobile phase
resulted in the best resolution.
II. Samples treated with 20% HCl solution and refluxed in an
85˚C water bath for 15 min resulted in a similar hydrolysis
level as that with 5.5% HCl solution and refluxed at the same
water bath for 30 min.
III. The correlation coefficients of linear regressions for
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quercetin, kaempferol and isorhamnetin were 0.9999, 0.9999
and 0.9989, respectively. The relative standard deviations for
intra-day assay of quercetin, kaempferol and isorhamnetin
were 0.29%, 0.28%, and 1.90%, respectively; inter-day assay
were 0.95%, 0.85%, and 1.67%, respectively. These results
indicated the assays were precise.
IV. The HPLC method developed in this study could apply to
analyze quercetin, kaempferol, and isorhamnetin in Ginkgo
biloba extract and other relevant products including filmcoated tablets, sugar-coated tablet, tablet, drop, and oral solution with excellent separation and without the interference of
excipients.
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摘

要

本研究針對有關銀杏葉浸膏原料及製劑內 qucercetin, kaempferol 及 isorhamnetin 之 HPLC 定量方法進行評
估，結果顯示，分析條件使用 Cosmosil 5C18-AR 層析管，以 MeOH : 0.3%H3PO4（1:1）為移動相，分離效果
良好。各成分檢量線之相關係數分別為 quercetin ｒ = 0.9999 ， kaempferol ｒ = 0.9999 ， isorhamnetin ｒ =
0.9989 ，而同日內檢測之相對標準偏差分別為 0.29% ， 0.28% ，及 1.90% ，異日間檢測之相對標準偏差分別
為 0.95% ， 0.85% 及 1.67% ，其添加回收率則分別為 87.4% ， 94.0% 及 72.4% 。另外檢體前處理之方法，使用
20%HCl 溶液經 15 分鐘加熱迴流，與使用 5.5%HCl 溶液經 30 分鐘加熱迴流，可得到相近之水解效果。
關鍵詞：銀杏葉浸膏，高效液相層析法， quercetin, kaempferol, isorhamnetin

